Fundraising Fox
Neuroclues
Louvain-la-Neuve, BE · Founded 2020 · 34 employees on LinkedIn · 3 known investors
Find your way into Neuroclues
Each arrow is one introduction. Sign up to fill in the first one.
Ask Pierre de Waha to introduce you to Antoine Pouppez
You →Pierre · together at Neuroclues →Antoine
Sign up to find every way you can get introduced to Neuroclues
- Your email: who you already know at Neuroclues, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Neuroclues team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Neuroclues develops eye-tracking technology to identify neurological disorders including Parkinson's, Alzheimer's, and Multiple Sclerosis before symptoms appear, serving clinicians and healthcare practitioners. The company combines hardware, software, and cloud systems to provide biomarkers for early disease detection.
Founders & leadership
Neuroclues was founded in 2020 by Pierre Daye, Pierre Pouget, and Antoine Pouppez.
Board
Investors · 3
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: Teampact.ventures's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Neuroclues do?
- Neuroclues develops eye-tracking technology to identify neurological disorders including Parkinson's, Alzheimer's, and Multiple Sclerosis before symptoms appear, serving clinicians and healthcare practitioners. The company combines hardware, software, and cloud systems to provide biomarkers for early disease detection.
- Who founded Neuroclues?
- Neuroclues was founded by Pierre Daye, Pierre Pouget, Antoine Pouppez in 2020.
- Who are Neuroclues's investors?
- Neuroclues's investors include Graph Ventures, Teampact.ventures, White Fund.
- Where is Neuroclues headquartered?
- Neuroclues is headquartered in Louvain-la-Neuve, BE.